Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma. (2023)
Attributed to:
AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jpba.2023.115436
PubMed Identifier: 37148698
Publication URI: http://europepmc.org/abstract/MED/37148698
Type: Journal Article/Review
Volume: 233
Parent Publication: Journal of pharmaceutical and biomedical analysis
ISSN: 0731-7085